| Dawn M Baumgartner, | |
|
564 N Idaho Rd, Apache Junction, AZ 85219-4002 | |
| (520) 689-2457 | |
| (520) 689-2745 |
| Full Name | Dawn M Baumgartner |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 564 N Idaho Rd, Apache Junction, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639399934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 12252 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dawn M Baumgartner, Po Box 3160, Apache Junction, AZ 85217-3160 Ph: (480) 288-5328 | Dawn M Baumgartner, 564 N Idaho Rd, Apache Junction, AZ 85219-4002 Ph: (520) 689-2457 |
News Archive
A new study out of Western University (London, Canada) illustrates the need for a lot more education around pharmacogenetics (PGx) -the study of how a patient's genes can affect drug reaction and dosage.
Biomedical engineers at Duke University have shown that the efficacy of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than simply concurrently administered.
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
› Verified 3 days ago
Mrs. Leanne Dorothy Millsap, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 150 N Ocotillo Dr, Apache Junction, AZ 85220 Phone: 480-983-0571 | |
Robert W. Young, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 564 N Idaho Rd, Apache Junction, AZ 85219 Phone: 480-288-5328 Fax: 480-288-5339 | |
Jaclynn C. Kearney, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 564 N Idaho Rd, Apache Junction, AZ 85219 Phone: 480-288-5328 Fax: 480-288-5339 | |
Mr. Russell Vernon Pearson, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 288 N Ironwood Dr, Apache Junction, AZ 85220 Phone: 480-982-2356 Fax: 480-982-2449 | |
Mr. Daniel E. Parke, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 288 N Ironwood Dr, Apache Junction, AZ 85220 Phone: 480-982-2356 Fax: 480-982-2449 | |
Brittainy L Warne-murphy, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 564 N Idaho Rd, Apache Junction, AZ 85119 Phone: 480-983-0065 Fax: 480-983-3676 | |
Mrs. Connie Forrester, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1030 N Valley Dr, Apache Junction, AZ 85120 Phone: 480-707-8213 |